Skip to main content

Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure?

  • Chapter
Book cover Vasodilators in Chronic Heart Failure
  • 58 Accesses

Abstract

The acute hemodynamic response to vasodilator drugs in patients with congestive heart failure is well known. In response to administration of drugs that dilate both arterial and venous vascular beds there is an increase in cardiac output, a reduction in right atrial and left atrial pressure, a reduction in pulmonary arterial pressure, a modest reduction in arterial pressure, and little change in heart rate. This hemodynamic response has been reported during infusion of sodium nitroprusside (1), and after oral administration of hydralazine and isosorbide dinitrate (2), prazosin (3), trimazosin (4), or captopril (5). Despite the salutary acute hemodynamic response to these drugs, the major question is whether chronic administration of any of these agents.will result in improved exercise performance, reduced morbidity, and longer life expectancy.

Supported in part by PHS Grant HL 22977 from the National Heart, Lung and Blood Institute

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Guiha NH, Cohn. JN, Mikulic E, Franciosa JA, Limas CJ (1974) Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291: 587

    Article  PubMed  CAS  Google Scholar 

  2. Pierpont GL, Cohn JN, Franciosa JA (1978) Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest 73: 8

    Article  PubMed  CAS  Google Scholar 

  3. Miller RR, Awan NA, Maxwell KS, Mason DT (1977) Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator, prazosin. N Engl J Med 297: 303

    Article  PubMed  CAS  Google Scholar 

  4. Franciosa JA, Cohn JN (1978) Hemodynamic effects of trimazosin in patients with left ventricular failure. Clin Pharmacol Ther 23: 11

    PubMed  CAS  Google Scholar 

  5. Levine TB, Franciosa JA, Cohn JN (1980) Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation 62: 35–41

    PubMed  CAS  Google Scholar 

  6. Franciosa JA, Cohn JN (1979) Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure. Circulation 59: 1085–1091

    PubMed  CAS  Google Scholar 

  7. Franciosa JA, Goldsmith SR, Cohn JN (1980) Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med 69: 559–566

    Article  PubMed  CAS  Google Scholar 

  8. Rubin SA, Chatterjee K, Gelberg HJ, Ports TA, Brundage BH, Parmley WW (1979) Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. Am J Cardiol 43: 810

    Article  PubMed  CAS  Google Scholar 

  9. Aronow W, Greenfield RS, Alimadadian H, Danahy DT (1977) Effect of the vasodilator trimazosin versus placebo on exercise performance in left ventricular failure. Am J Cardiol 40: 789

    Article  PubMed  CAS  Google Scholar 

  10. Franciosa JA, Nordstrom LA, Cohn JN (1978) Nitrate therapy for congestive heart failure. JAMA 240: 433

    Article  Google Scholar 

  11. Weber KT, Kinasewitz GT, West JS, Janicki JS, Reichek N, Fishman AP (1980) Long-term vasodilator therapy with trimazosin in chronic cardiac failure. N Engl J Med 303: 242–249

    Article  PubMed  CAS  Google Scholar 

  12. Colucci WS, Wynne J, Holman BL, Braunwald E (1980) Long-term therapy of heart failure with prazosin, a randomized double-blind trial. Am J Cardiol 45: 337–343

    Article  PubMed  CAS  Google Scholar 

  13. Holloszy JO (1976) Adaptations of muscular tissue to training. Prog Cardiovasc Dis 18: 445

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cohn, J.N. (1983). Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure?. In: Just, H., Bussmann, WD. (eds) Vasodilators in Chronic Heart Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68605-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68605-4_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68607-8

  • Online ISBN: 978-3-642-68605-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics